NCT05828836

Allopurinol and Quality of Life in Liver Cirrhosis

the Impact of Allopurinol of HRQOL in Cirrhotic Patients

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Tanta University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The study aims to evaluate the impact of allopurinol on patients' related quality of life.

Detailed description

Cirrhosis is the late stage of liver damage and possess two phases:. The shift from compensated to decompensated cirrhosis is characterized by the onset of complications) which are associated with substantial morbidity and negative Impact on quality of life (QOL)Cirrhosis and its complications have a substantial economic, social, and personal impact on affected patients, as well as their families and caregivers

Conditions

• Cirrhosis, Liver

Interventions

Type	Name	Description
DRUG	Allopurinol Tablet	allopurinol300mg once daily
DRUG	Placebo	placebo once daily

Timeline

• Start date: 2022-06-15
• Primary completion: 2023-01-15
• Completion: 2023-03-01
• First posted: 2023-04-25
• Last updated: 2023-10-31

Locations

1 site across 1 country: Egypt